Are Biomaterials Revolutionizing the Medical Device Industry? - A Fresh Perspective F

PALO ALTO, Calif., Feb. 8 /PRNewswire/ – The Technical Insights, Chemicals, Materials & Food Group at Frost & Sullivan is pleased to announce its Exclusive 2007 Quarterly Webinar on Thursday, February 15, 2007 at 11:00 a.m. EST.The field of biomaterials is multidisciplinary in nature. The vastness of the field coupled with its ability to cater to the medical needs of various patients enables it to have a huge impact on the quality of a patient’s life. The capacity of these biomaterials to efficiently interact with living human tissues is revolutionizing medical technology and hence will always remain an exciting area for study and application.
Highlights of the briefing include: an analysis of drivers, restraints and challenges currently faced by the industry, analyzing the strength and weakness and developments seen in metal, polymer, composite and ceramic based biomaterials.
“Similar to the prevailing scenario, the future of biomaterials might have an important role in medical technologies as there are many potential applications for these materials in medical devices and drug-delivery systems.” says Frost & Sullivan Research Analyst R. Srimathy. “However, biomaterials might have to face tough competition from stem-cell technology; as this technology too has the potential to act as natural replacements for tissues and organs. But, there is still a long way to go for this technology to succeed and hence it is still an uncertain prospect.”
Those interested in participating in the interactive webinar should send an email to Vanessa Quezada – Corporate Communications at vanessa.quezada@frost.com with the following information: your full name, company name, title, telephone number, email address, city, state and country. She will send the registration details via email upon receipt of the above information.
This briefing will benefit those medical device manufacturers who develop dental implants, prosthesis for repairing the natural tissues, vascular grafts, heart valves, pacemakers, artificial heart and ventricular assist device components, stents, balloons, and blood substitutes, cochlear implants, tissue screws and tacks, burn and wound dressings and artificial skin, tissue adhesives and sealants, drug-delivery systems, matrices for cell encapsulation and tissue engineering, and sutures.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services and corporate management training to identify and develop opportunities. While serving clientele including Global 1000 companies, emerging companies, and the investment community, Frost & Sullivan’s comprehensive industry coverage includes a unique global perspective that combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com/ .
Contact: Vanessa Quezada Corporate Communications - North America P: 210-477-8427 F: 210.348.1003 E: vanessa.quezada@frost.com http://www.frost.com http://www.ti.frost.com